Phase II Trial of Anti-PD-1 Antibody Treatment and Radiotherapy in Early-stage Favorable Classic Hodgkin Lymphoma
Clinical trial NCT06916416 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06916416
- Sponsor
- University of Cologne
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-01
- Primary completion
- 2026-06-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.